IMG-EN-AS-60431-1-01.jpg
Peptides

ADAMTS-4/Aggrecanase FRET Substrate, WAAG-3R - 1 mg

$296.00
Check your price
  • Cat.Number : AS-60431-1
  • Availability :
    In stock

Quantity

Add to wishlist Bulk Quote

Aggrecanases belong to the ADAMTS (A disintegrin and metalloprotease with thrombospondin motif) family of proteases. Aggrecanases cleave aggrecan, the major structural component of cartilage. Aggrecanase-1 (ADAMTS-4) is a major aggrecanase in human osteoarthritic cartilage.
This FRET peptide was used in an ADAMTS-4 (Aggrecanase-1) assay. Ex/Em = 340/420 nm.

Specifications

Chemistry
Sequence one letter code
  • Abz-TEGEARGSVI-Dap(Dnp)-KK-NH2
Sequence three letter code
  • Abz-Thr-Glu-Gly-Glu-Ala-Arg-Gly-Ser-Val-Ile-Dap(Dnp)-Lys-Lys-NH2
Molecular Formula
  • C69H109N23O24
Molecular Mass/ Weight
  • 1644.8
Properties
Absorbance (nm)
  • 340
Emission (nm)
  • 420
Modification
Conjugation type
  • Double dyes
Modification Name
Conjugation
  • Conjugated
Quantity & Purity
Purity
  • Peak Area by HPLC ≥95%
Storage & stability
Form
  • Lyophilized
Storage Conditions
  • - 20 °C Protected from light
Activity
Application
Biomarker Target
Detection Method
Research Area
Sub-category Research Area
Usage
  • Research use
Source
Source / Species
  • human

Downloads

You may also be interested in the following product(s)

IMG-EN-AS-55576-1-01.jpg

MMP-9 (Catalytic Domain), human recombinant

Cat.Number : AS-55576-1
$119.00 Excl. Tax
IMG-EN-AS-71158-01.jpg

SensoLyte® 520 Generic MMP Activity Kit Fluorimetric - 1 kit

Cat.Number : AS-71158
$554.00 Excl. Tax

Citations

Divergent pathways for the angiotensin-(1–12) metabolism in the rat circulation and kidney

Peptides. . 2012 Apr 03 ; 35(2) 190 | DOI : 10.1016/j.peptides.2012.03.025

  • BM. Westwood
  • MC. Chappell

The Design and Synthesis of Novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis

Bioorg Med Chem Lett. . 2011 Jan 18 ; 21(5) 1376 | DOI : 10.1016/j.bmcl.2011.01.036

  • C. Savi

References

Identification and Characterization of 4-[[4-(2-Butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a Novel Dual Tumor Necrosis Factor-α-Converting Enzyme/Matrix Metalloprotease Inhibitor for the Treatment of Rheumatoid Arthritis

J Pharmacol Exp Ther . 2004 Apr 01 ; 309(1) 348 | DOI : https://doi.org/10.1124/jpet.103.059675

  • Y. Zhang
  • et al